Sky9 Capital
云九资本
Sky9 Capital is a venture capital fund that invested in Moonshot AI . The bundle contains no further details on its vintage, AUM, team, or other portfolio companies.
AI-generated — may contain errors, please verify.
Coverage
Former LiblibAI Co-founder Raises Tens of Millions in USD for New Startup, Using "World Simulator" to Break Into AI Entertainment
Find a "milk-tea kind" of happiness in a self-created virtual world.
暗涌Waves·Another VC Rebrands with a New Name
The twentieth year of local iteration.
暗涌Waves·2024, When Everyone Stands at a Crossroads: 96 Investors' Decisions
Deciding is easy. Waiting is hard.
暗涌Waves·5Y News | 5Y Capital Portfolio Company ReviR Therapeutics Raises $30 Million in Series A Funding
Continuing to advance "oral gene therapy" through AI+RNA.
五源资本·Exclusive | Moonshot AI's valuation reaches $3 billion in new round; Tencent joins after Alibaba
A full list of Moonshot AI's investors to date.
暗涌Waves·Money, Contradictions, and ESG
*Who Cares Wins*
暗涌Waves·Three Barometers for the Primary Market, for Your Reference
The bilateral order of the primary market is being restructured on both sides.
暗涌Waves·Capital O Closes First Fund, Post-90s GP Enters the Stage
Technological breakthroughs deserve more attention than market turbulence.
暗涌Waves·Linear Capital Leads Pre-A Round in CloudNat Technology, Follows On in Series A with Pro-Rata Allocation | Linear News
Dedicated to driving agile digital transformation for enterprises.
线性资本·Linear News | SynBio Startup "Biosys" Secures Two Funding Rounds in Six Months, Linear Capital Leads Angel Round
"Besheng Bio's" long-term goal is to build a complete biotech ecosystem based on the ArchiCel architecture — in essence, to create the Windows + x86 equivalent for the biotechnology industry.
线性资本·February: When the Tiger Roars, the Wind Rises | 5Y News Monthly
The big news from last month.
五源资本·5Y News | AI+RNA Startup ReviR Therapeutics Closes Tens of Millions of Dollars in Pre-A Round
Using AI algorithms and gene technology to drive targeted RNA drug development.
五源资本·2022, the Door Opens to the Future | 5Y News Monthly
The big news from last month.
五源资本·5Y News | AI Microbiome Drug Developer "Unknown" Closes Nearly $100 Million Series B Financing
Launching a new AI×BT strategy.
五源资本·November: Foresight and Boundless Imagination | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Signet Therapeutics Raises Nearly $10 Million to Power AI-Enabled Innovative Targeted Drug Development Through Disease Modeling Platform
Advancing pharmaceutical innovation in China.
五源资本·As Fierce as August | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Neox Biotech Completes Tens of Millions of Dollars in Series A+ Funding to Advance Innovative Drug Pipeline
5Y Capital continues to provide support.
五源资本·To Better Kick Off March | 5Y News Monthly
The major events of February.
五源资本·5Y News｜Neox Biotech Completes $30 Million Series A Round, 5Y Capital Continues Support
Exploring the most cutting-edge drug modalities.
五源资本·General-Purpose Intelligent Chip Designer Biren Technology Completes Major Pre-B Round Financing
Dedicated to achieving breakthroughs in domestically produced high-end general-purpose AI computing chips.
高榕创投·
